It’s really a great pity that we did not have the opportunity to study Exo70 expression in different subtypes to interpret the colon cancer heterogeneity in our current cohort, because this molecular classification is not yet recommended in clinical practice (i.e., no information about the molecular classification of our current clinical samples was provided) and our study is retrospective. Here, EXOC7 is linked to colonic neoplasm.